Sequoia Financial Advisors LLC Reduces Position in STERIS plc (NYSE:STE)

Sequoia Financial Advisors LLC lessened its holdings in shares of STERIS plc (NYSE:STE) by 1.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,826 shares of the medical equipment provider’s stock after selling 322 shares during the period. Sequoia Financial Advisors LLC’s holdings in STERIS were worth $3,870,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of STE. Ashton Thomas Securities LLC purchased a new position in shares of STERIS during the third quarter valued at approximately $25,000. Human Investing LLC purchased a new stake in shares of STERIS in the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC boosted its holdings in shares of STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division boosted its holdings in shares of STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its holdings in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Stock Down 0.9 %

Shares of NYSE STE opened at $222.39 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $21.85 billion, a PE ratio of 47.22 and a beta of 0.92. The stock’s fifty day simple moving average is $218.71 and its two-hundred day simple moving average is $222.64. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.03%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

Wall Street Analysts Forecast Growth

STE has been the subject of a number of research reports. Piper Sandler boosted their price target on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Stephens reiterated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.